Search

Your search keyword '"Shapiro CL"' showing total 229 results

Search Constraints

Start Over You searched for: Author "Shapiro CL" Remove constraint Author: "Shapiro CL"
229 results on '"Shapiro CL"'

Search Results

1. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years

2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

3. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

4. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

9. Abstract P2-11-07: Endothelial progenitor cells as novel markers of anthracycline induced cardiac injury

17. A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.

18. Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.

19. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

28. Ovarian ablation in early breast cancer: Overview of the randomised trials

29. EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS

30. Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis.

31. Transportation barriers, emergency room use, and mortality risk among US adults by cancer history.

32. Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort.

33. Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis.

36. Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018.

37. Bone-modifying Agents (BMAs) in Breast Cancer.

38. Quality Care in Survivorship: Lessons Learned From the ASCO Quality Oncology Practice Initiative.

39. A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.

40. Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments.

41. Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis.

42. Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.

45. Metastatic breast cancer patient perceptions of somatic tumor genomic testing.

46. Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.

47. Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.

48. Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline.

50. Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance.

Catalog

Books, media, physical & digital resources